Syneron Medical, an aesthetic device company, has received 510(k) clearance from the US Food and Drug Administration (FDA) to market a new Tanda Light Emitting Diode (LED) system for skin rejuvenation.
The Tanda skin rejuvenation product is approved for the treatment of wrinkles, rhytides and fine lines in the periorbital (around the eye) region.
Syneron executive vice president Fabian Tenenbaum said this new system, which is more powerful and expands the indications for the Tanda’s LED technology, demonstrates the broad applications of LED and the strong growth opportunity that we see for the business.
The new Tanda skin rejuvenation system joins the Tanda family of products from Pharos Life, a manufacturer of home-use light therapy devices for aesthetic procedures, acquired by Syneron Medical in December 2010.
The system utilizes a new luminous LED array that delivers concentrated channels of light for a fractional phototherapy effect.
The super luminous LED allows the new system to deliver five-times greater power than the existing Tanda family of products, reducing the required number of treatments to two treatments per week.